Somatropin biosimilar (Sandoz)

生长激素生物类似药（山德士）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSomatropin biosimilar (Sandoz)
Drug Alias Name生长激素生物仿制药（山德士）Omnitrope
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyIdiopathic short statureDeficiency Diseases +[7] 
Global Approved IndicationsGrowth hormone deficiencyIdiopathic short statureDeficiency Diseases +[7] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2006/04/12
Country/TerritoryUnited StatesEUJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSandoz
China Registration ClassN/A

Develop Information

Active CompaniesClariant Produkte (Schweiz) AgSandoz Gmbh
Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiencyIdiopathic short statureDeficiency Diseases +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeH01AC01
Related LinksN/A